- Apixaban versus Warfarin in Patients with Chronic Kidney Disease; A Systematic Review and Meta-analysis
-
Nam JH, Kim CY, Lee YK, Jung DW, Gwak HY, Chung JE
- KMID: 2517306
- Korean J Clin Pharm.
- 2021 Jun;31(2):87-95.
- doi: 10.24304/kjcp.2021.31.2.87
Background: Patients with chronic kidney disease (CKD) are at a high risk of stroke-related morbidity, mortality, and bleeding. However, the overall risk/benefit of anticoagulant therapy among patients with CKD remains... -
- CITED
-
- Close
- SHARE
-
- Close
